Tools commonly used in the Infertility Treatment industry for day-to-day tasks and operations.

• Ovulation predictor kits
• Fertility monitors
• Sperm analysis kits
• Ultrasound machines
• Hormone injections
• Intrauterine insemination catheters
• Embryo transfer catheters
• Cryopreservation equipment
• Microscopes
• Laparoscopes

Common products and services typical of NAICS Code 621399-09, illustrating the main business activities and contributions to the market.

• In vitro fertilization
• Artificial insemination
• Egg donation
• Sperm donation
• Surrogacy
• Intracytoplasmic sperm injection
• Assisted hatching
• Preimplantation genetic testing
• Fertility preservation
• Donor embryo transfer

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• American Board Of Obstetrics and Gynecology (ABOG) Certification: This certification is required for physicians who specialize in obstetrics and gynecology, which includes infertility treatment. The certification is provided by the American Board of Obstetrics and Gynecology.
• American Board Of Medical Specialties (ABMS) Certification: This certification is required for physicians who specialize in reproductive endocrinology and infertility, which is a sub-specialty of obstetrics and gynecology. The certification is provided by the American Board of Medical Specialties.
• Clinical Laboratory Improvement Amendments (CLIA) Certification: This certification is required for laboratories that perform diagnostic testing on human specimens, including those used in infertility treatment. The certification is provided by the Centers for Medicare & Medicaid Services.
• Society for Assisted Reproductive Technology (SART) Membership: This membership is required for clinics that provide assisted reproductive technology (ART) services, which includes infertility treatment. The membership is provided by the Society for Assisted Reproductive Technology.
• Accreditation Association for Ambulatory Health Care (AAAHC) Accreditation: This accreditation is required for ambulatory healthcare organizations, including those that provide infertility treatment. The accreditation is provided by the Accreditation Association for Ambulatory Health Care.

A concise historical narrative of NAICS Code 621399-09 covering global milestones and recent developments within the United States.

• The history of infertility treatment dates back to ancient times, where various remedies and rituals were used to treat infertility. In the 18th century, the first successful artificial insemination was performed on a dog, and in the 19th century, the first successful human artificial insemination was performed. In the 20th century, the first successful in vitro fertilization (IVF) was performed in the UK, and the first IVF baby was born in 1978. Since then, the industry has seen significant advancements, including the development of intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). In the United States, the first successful IVF baby was born in 1981, and since then, the industry has grown significantly, with more than 1% of all babies born in the US being conceived through IVF. The industry has also seen advancements in egg freezing, surrogacy, and other assisted reproductive technologies.

The anticipated future trajectory of the NAICS 621399-09 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The infertility treatment industry in the USA is expected to grow in the coming years due to the increasing number of couples seeking fertility treatments. The industry is expected to benefit from advancements in technology, such as the development of new fertility drugs and procedures, as well as the increasing use of artificial intelligence and machine learning in fertility treatments. Additionally, the growing awareness and acceptance of fertility treatments among the general population is expected to drive demand for infertility treatment services. However, the industry may face challenges such as increasing competition and regulatory hurdles in the future.

Recent groundbreaking advancements and milestones in the Infertility Treatment industry, reflecting notable innovations that have reshaped its landscape.

• In vitro fertilization (IVF) with pre-implantation genetic testing (PGT) has become more common in recent years. This technology allows for the screening of embryos for genetic abnormalities before implantation, increasing the chances of a successful pregnancy and reducing the risk of genetic disorders.
• The use of frozen donor eggs has become more popular in recent years, allowing for greater flexibility in scheduling and reducing the cost of treatment.
• The development of new fertility drugs, such as gonadotropin-releasing hormone (GnRH) antagonists, has improved the effectiveness of fertility treatments and reduced the risk of side effects.
• The use of artificial intelligence and machine learning in fertility treatments has allowed for more accurate predictions of fertility outcomes and personalized treatment plans.
• The increasing use of telemedicine in the infertility treatment industry has allowed for greater access to care, particularly in rural areas where access to fertility specialists may be limited.